Village Farms International (VFF) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates advanced greenhouse facilities in British Columbia and Texas, producing tomatoes, bell peppers, and cucumbers.
Subsidiaries include a vertically integrated cannabis producer and a CBD product developer with operations in Canada and the US.
Holds significant cannabis market presence in Quebec and owns a majority stake in a Dutch cannabis company.
Incorporated in Ontario, with principal offices in Canada and shares listed on Nasdaq under the symbol VFF.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for working capital and general corporate purposes.
Management retains broad discretion over allocation of proceeds unless specified in a prospectus supplement.
Risk factors and disclosures
Faces risks from limited operating history in cannabis, regulatory uncertainties, integration of acquisitions, and market competition.
Exposed to risks from legal status of cannabis, regulatory compliance, product pricing variability, and cross-border trade.
Additional risks include inflation, energy costs, labor issues, and potential litigation.
U.S. investors may face challenges enforcing civil liabilities against directors and officers residing in Canada.
Latest events from Village Farms International
- Record 2025 profit, strong cannabis sales, and expansions support future growth.VFF
Q4 202512 Mar 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20243 Feb 2026 - Record sales growth in Canadian cannabis and produce, but net loss widened by U.S. impairment.VFF
Q2 20242 Feb 2026 - Q3 sales up 20%, driven by Canadian cannabis, fresh produce, and international growth.VFF
Q3 202416 Jan 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20256 Jan 2026 - Full-year sales up 18% to CAD 336M; international medicinal sales to triple in 2025.VFF
Q4 202425 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and diversity.VFF
Proxy Filing2 Dec 2025 - Canadian Cannabis EBITDA up 64%, international exports up 285%, $40M produce asset sale.VFF
Q1 202526 Nov 2025 - Record Q2 profit, surging cannabis margins, and global expansion drive strong outlook.VFF
Q2 202523 Nov 2025